Pharmaceutical Technology

FEBRUARY 3, 2023

The field of genomic medicine has reached a true turning point. With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more.

Genome 244

Genome Genomics Medicine Gene Therapy 244

FDA Law Blog

NOVEMBER 2, 2023

While on the surface this may not seem like major advance for the field, this could be a game changer for the gene therapy space. These meetings have a question-and-answer format to provide clarity to sponsors about the particular topics at hand.

Medicine 59

Medicine Gene Therapy Gene Production 59

Pharmaceutical Technology

DECEMBER 9, 2022

In regards to the latter, notable examples include the acquisition of Cergentis, a genomics-focused biotechnology company based in the Netherlands. The deal allows the company to provide proprietary technology and knowledge steeped in fast-evolving genomic techniques that support effective decision-making and R&D program design.

Development 130

Development Production Manufacturing Vaccination 130

Cloudbyz

AUGUST 9, 2023

Future-proofing Clinical Research The nature of clinical research is evolving, with personalized medicine, genomics, and digital health becoming more prominent. Streamlined workflows, reduced errors, enhanced scalability, and quicker trial durations all contribute to cost efficiencies.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

The Pharma Data

MAY 5, 2021

. Affinia Therapeutics raises $110 million for gene therapy treatments ( STAT ). New variant-hardy AbCellera-Lilly mAb shows utility of viral genomics surveillance ( BioCentury ). Startup sets out to tackle the gene therapy manufacturing crisis ( Endpoints ). Medtech.

Vaccination 52

Vaccination Vaccine Gene Therapy Contract Packaging 52